• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS ESHEATH+ INTRODUCER SET; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EDWARDS ESHEATH+ INTRODUCER SET; INTRODUCER, CATHETER Back to Search Results
Model Number 916ESP
Device Problems Difficult to Insert (1316); Peeled/Delaminated (1454); Material Puncture/Hole (1504)
Patient Problem Unspecified Vascular Problem (4441)
Event Date 08/16/2022
Event Type  Death  
Manufacturer Narrative
Investigation is ongoing.
 
Event Description
During a tavr procedure using a 29mm sapien 3 valve via transfemoral approach, the operator lost wire access to the left ventricle (lv).The operator attempted to recross but were unsuccessful, and the system was removed and prepped a 2nd device.Upon insertion of the 2nd valve system, the patient's pressure dropped to 40/20 when a perforation occurred at the distal aorta just above the iliac bifurcation.Information received from the sales director indicated that there was an island of calcium at the aortic perforation site.The perforation was possibly due to the insertion of the esheath and the 2nd delivery system and valve being advance through the sheath, impacting on the island of calcium.The operators attempted to pull the delivery system out of the esheath, but they pulled the crimped valve off of the balloon and it remained stuck in the mid portion of the sheath.The patient ultimately expired on the table after 25 minutes of cpr and discussion with vascular surgery on whether or not to attempt a vascular salvage (declined).
 
Manufacturer Narrative
Correction to h6; component code, device code, type of investigation, investigation findings, investigation conclusion.Update to d4- model number added.Although the device was expected to be returned, the hospital risk management department has not released the device for evaluation.The 16 fr esheath plus was not returned to edwards lifesciences for evaluation; therefore, no visual inspection, functional testing, and dimensional testing are applicable.A photograph of the esheath was provided and the sheath liner appears torn at the middle of the shaft and the hdpe had damage in that region.The liner appears otherwise expanded as designed.The esheath+ ifu, commander delivery system ifu, and device and procedural preparation manual instructions for use (ifu) were reviewed.The device preparation manual provides guidance on vascular access.Access characteristics that would preclude safe placement of the sheath such as severe obstructive calcification, severe tortuosity, or vessel diameters less than the minimum recommended (less than 5.5 mm or 6 mm) should be carefully assessed prior to the procedure.Based on this review, no ifu training deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaints for sheath liner torn and sheath punctured were confirmed from the imaging evaluation, while the complaint of difficulty introducing the sheath was unable to be confirmed.As the lot number was not provided, reviews of the dhr and lot history were unable to be performed.Without the returned device, no testing could be performed; therefore, no manufacturing non-conformance could be identified.A review of the complaint history showed no indication of a manufacturing non-conformance contributed to the event.No ifu/training manual deficiencies were identified.Furthermore, no abnormalities were reported during device unpacking or preparation.As described, "resistance was felt while inserting the esheath+ into the patient, and the tip of the sheath was hitting the lateral aspect of the abdominal aorta proximal to iliac artery bifurcation.There was an island of calcium at this site, and the operator was unable to guide the tip of the esheath around into its final position in the abdominal aorta".An "island of calcium" can induce friction on the sheath during attempts to navigate past.Several factors could have contributed to the damage observed.As reported, "only 1 sheath was used on this procedure".The first delivery system was removed through the sheath, whereas the training manual states during thv retrieval through the sheath, "withdraw the delivery system and sheath as a single unit completely from the arteriotomy while maintaining guidewire position".Excessive re-use of the sheath during multiple attempts at guidewire replacement, multiple delivery system introduction, and coda balloon intervention, could have contributed to the damage on the sheath throughout the procedure.The ifu states, "the devices are designed, intended, and distributed for single use only".The presence of the "island of calcium" could weaken the sheath liner resulting in the liner tear.Also reported, "the operator pulled the delivery system too fast through the esheath causing the crimped valve to move of the delivery systems balloon and was stuck in the mid-portion of the esheath".The forceful removal of the delivery system within the sheath likely caused the shaft damage and contributed to the liner tear as the valve struts likely caught onto the shaft and liner.In this case, available information suggests the following contributed to the events: patient factors (calcification) contributed to the difficulties in introducing the sheath.Patient factors (calcification), procedural factors (excessive manipulation, withdrawal of crimped valve), and use error (sheath re-use) contributed to the liner tear.Procedural factors (excessive manipulation, withdrawal of crimped valve) and use error (sheath re-use) contributed to the shaft damage.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS ESHEATH+ INTRODUCER SET
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key15396023
MDR Text Key299657461
Report Number2015691-2022-07813
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K200258
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/09/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number916ESP
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient SexMale
-
-